China welcomes new US$1 billion Sanofi project in Beijing

Quick Summary:

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

The Beijing project reflects Sanofi’s optimism in its prospects in the country amid steady economic cooperation between China and the European Union in spite of tensions related to trade and the war in Ukraine.

Exterior view of Sanofi’s offices in Gentilly, France.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Xinmei Shen

Category: Business

Markets: Hong KongChinaFranceUkraine

Topics: Pharmaceutical European Report Country Beijing China Billion Oudéa Plant According Sanofi

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-03 @ 20:00:09 (1 days ago)

News Timezone: GMT +8:00

News Source URL: scmp.com

Language: English

Article Length: 230 words

Reading Time: 2 minutes read

Sentences: 9 lines

Sentence Length: 26 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © SCMP

News ID: 24091555

View Article Analysis

About SCMP

Main Topics: Business

Official Website: scmp.com

Update Frequency: 12 posts per day

Year Established: 1903

Headquarters: Hong Kong

News Last Updated: 34 minutes ago

Coverage Areas: Hong Kong

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #42

Publisher Details

Frequently Asked Questions